Hosoi Hiroki, Warigaya Kenji, Murata Shogo, Mushino Toshiki, Kuriyama Kodai, Nishikawa Akinori, Tamura Shinobu, Hatanaka Kazuo, Hanaoka Nobuyoshi, Muragaki Yasuteru, Murata Shinichi, Nakakuma Hideki, Sonoki Takashi
Department of Hematology and Oncology, Wakayama Medical University , Wakayama, Japan.
Department of Human Pathology and Diagnostic Pathology, Wakayama Medical University , Wakayama, Japan.
Hematol Rep. 2016 Jun 27;8(2):6482. doi: 10.4081/hr.2016.6482. eCollection 2016 May 10.
We report cases of three patients of refractory ascites without other fluid retention that occurred around five months after allogeneic hematopoietic stem cell transplantation (allo-HSCT). All three patients expired and postmortem examinations revealed unexpected liver fibrosis lacking histological evidences of graft-versus-host-disease (GVHD). The three patients showed normal hepatic function and size before transplantation. During their clinical courses, serum biochemistry test showed no elevation of hepatic enzymes and bilirubin; however, imaging studies demonstrated hepatic atrophy at the onset of ascites. One of the liver specimens showed bile obstruction, which could be seen in hepatic damage by GVHD. Although ascites resulting from venoocclusive disease in early phase allo-HSCT is well documented, ascites associated with hepatic fibrosis in late phase allo-HCST has not been reported. Further clinico-pathological studies on similar patients should be required to ascertain refractory ascites associated with liver fibrosis after allo-HSCT.
我们报告了3例难治性腹水患者的病例,这些患者在异基因造血干细胞移植(allo-HSCT)后约5个月出现,无其他液体潴留情况。所有3例患者均死亡,尸检显示存在意外的肝纤维化,缺乏移植物抗宿主病(GVHD)的组织学证据。这3例患者在移植前肝功能和肝脏大小均正常。在其临床病程中,血清生化检查显示肝酶和胆红素未升高;然而,影像学研究显示腹水出现时肝脏萎缩。其中一份肝脏标本显示有胆汁梗阻,这在GVHD导致的肝损伤中可见。虽然早期allo-HSCT中由肝静脉闭塞病引起的腹水已有充分记录,但晚期allo-HCST中与肝纤维化相关的腹水尚未见报道。需要对类似患者进行进一步的临床病理研究,以确定allo-HSCT后与肝纤维化相关的难治性腹水。